Lanetta B Jordan
Associate Professor of the Department of Epidemiology and Public Health Sciences at the University of Miami.
She is President of the Foundation for Sickle Cell Disease Research.
The Sickle Cell Disease Association of America Inc.,
Baltimore, USA
Lanetta B. Jordan, MD, MPH, MSPH is an Associate Professor of the Department of Epidemiology and Public Health Sciences at the University of Miami, Miller School of Medicine and a Senior Medical Advisor, Centers for Disease Control and Prevention. She is President of the Foundation for Sickle Cell Disease Research that aims to support innovative research in sickle cell and disease and hemoglobinopathies. She serves as Editor-in-Chief for the Journal of Sickle Cell Disease and Hemoglobinopathies, an online peer reviewed journal. Of note, she previously established and consequently directed the Department of Sickle Cell Services at Memorial Healthcare System for twelve years, with its “Sickle Cell Day Hospital” being the first of its kind in the nation to receive “Disease-Specific Certification” from The Joint Commission. The crux of her work and contributions focus on Sickle Cell Disease which run the gamut from elimination of health and health care disparities, care coordination, establishing all encompassing treatment, continuity of care guidelines and clinical research. One of the hallmarks of her dedication to this disease was to help steer the development of a Sickle Cell Disease and Thalassemia National Registry and Health Record. Dr. Jordan’s experience is rife with professional affiliations and contributions on both Local and National Boards and Advisory Councils such as the National Heart, Lung and Blood Advisory Council of the National Institutes of Health, Chief Medical Officer for the Sickle Cell Disease Association of America and the Greater Miami-Dade YWCA. For eight years she has hosted a Sickle Cell Disease Research and Educational Symposium, which draws physicians, nurses, scientists and policymakers from around the world with expertise in basic, clinical, translational and public health research and clinical care.
sickle cell and disease and hemoglobinopathies.